After COVID vaccines, time to use mRNA tech against other infectious diseases
March 12, 2022
The geopolitics of science and technology: GZERO's news coverage and analysis of how scientific and tech developments impact the world's economy and society.
Presented by
Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.
But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "
There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.
Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.
Keep up with what’s going on around the world - and why it matters.